Skip to main content
. 2017 Oct 16;90(1079):20170361. doi: 10.1259/bjr.20170361

Table 3.

Comparison of imaging findings of malignant peritoneal mesothelioma (n = 34) between 22 patients who underwent CC and 12 patients who underwent MTD

Variables CC (n = 22) MTD (n = 12) p value
Sex M:F = 12:10 M:F = 8:4 0.377
Age 51 ± 11.2 years (29–67 years) 65.3 ± 9.7 years (51–79 years) 0.001
Disease extent:      
Diffuse 19 12 0.257
Localized 3 0
Ascites 16 10 0.402
Solid masses present 5 3 0.584
Size of solid mass 12.3 ± 7.2 cm (6.5–25 cm) 9.4 ± 5.9 cm (4.3–16 cm)
Peritoneal thickening 17 11 0.290
Micronodular 8 5
Macronodular 7 3
Plaques 7 6
Papillary 2 1
Omental disease 19 12 0.257
Omental caking 12 11
Fine stranding 7 1
Mesenteric involvement 14 10 0.211
Mesenteric fold thickening: 14 10
Mesenteric retraction 2 0
Mesenteric mass 3 2
Small bowel involvement 7 9 0.019
Mural thickening 4 4 0.279
Distortion of bowel lumen 6 8 0.031
Rind around small bowel 1 7 0.001
Small bowel obstruction and compartmental­ization 1 1 0.588
Yan CT grading      
Class 0 5 1 0.694
Class I 6 3
Class II 9 6
Class III 2 2
Subphrenic disease 2 1 0.721
Upper abdominal disease 2 ± 2 5 ± 4 0.025
Radiological PCI 16 ± 11 24 ± 12 0.048
Surgical PCI 17 ± 12 (3–39), N = 13 34 ± 5 (25–39), N = 8 < 0.001
Recurrence 6 1 0.379
Survival 43.6 ± 42 months (5–89 months) 23.5 ± 23.5 months (5–67 months) 0.074
Alive 18 6 0.102
Dead 4 5

CC, complete cytoreduction; MTD, majortumour debulking.